Catalyst Wire Dossier Catalyst Wire Dossier

Leniolisib

leniolisib · Pharming Technologies B.V.
Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for Leniolisib, covering 2024-02-08 to 2026-02-13. Get the full timeline:

Most recent: Clinical Trial Update: Leniolisib for Immune Dysregulation in PIDs [Phase 2]

See pricing